company background image
4WK

Wenzhou Kangning Hospital DB:4WK Stock Report

Last Price

HK$1.38

Market Cap

HK$105.6m

7D

0.7%

1Y

-50.7%

Updated

17 May, 2022

Data

Company Financials +
4WK fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance5/6
Financial Health5/6
Dividends0/6

4WK Stock Overview

Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People’s Republic of China.

Wenzhou Kangning Hospital Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Wenzhou Kangning Hospital
Historical stock prices
Current Share PriceHK$1.38
52 Week HighHK$5.60
52 Week LowHK$0.83
Beta0.26
1 Month Change3.76%
3 Month Change21.05%
1 Year Change-50.71%
3 Year Change-70.94%
5 Year Change-65.83%
Change since IPO-74.58%

Recent News & Updates

Shareholder Returns

4WKDE HealthcareDE Market
7D0.7%0.2%4.2%
1Y-50.7%-19.0%-11.4%

Return vs Industry: 4WK underperformed the German Healthcare industry which returned -19.8% over the past year.

Return vs Market: 4WK underperformed the German Market which returned -12.4% over the past year.

Price Volatility

Is 4WK's price volatile compared to industry and market?
4WK volatility
4WK Average Weekly Movement10.8%
Healthcare Industry Average Movement5.2%
Market Average Movement6.4%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market3.5%

Stable Share Price: 4WK is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: 4WK's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
19963,763Lianyue Wanghttps://www.knhosp.cn

Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People’s Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services.

Wenzhou Kangning Hospital Fundamentals Summary

How do Wenzhou Kangning Hospital's earnings and revenue compare to its market cap?
4WK fundamental statistics
Market CapCN¥749.23m
Earnings (TTM)CN¥76.50m
Revenue (TTM)CN¥1.19b

9.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4WK income statement (TTM)
RevenueCN¥1.19b
Cost of RevenueCN¥845.31m
Gross ProfitCN¥343.64m
Other ExpensesCN¥267.13m
EarningsCN¥76.50m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.06
Gross Margin28.90%
Net Profit Margin6.43%
Debt/Equity Ratio41.1%

How did 4WK perform over the long term?

See historical performance and comparison

Valuation

Is Wenzhou Kangning Hospital undervalued compared to its fair value and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 4WK (€1.38) is trading below our estimate of fair value (€7.51)

Significantly Below Fair Value: 4WK is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 4WK is good value based on its PE Ratio (9.8x) compared to the German Healthcare industry average (19x).

PE vs Market: 4WK is good value based on its PE Ratio (9.8x) compared to the German market (17.5x).


Price to Earnings Growth Ratio

PEG Ratio: 4WK is good value based on its PEG Ratio (0.6x)


Price to Book Ratio

PB vs Industry: 4WK is good value based on its PB Ratio (0.6x) compared to the DE Healthcare industry average (1.3x).


Future Growth

How is Wenzhou Kangning Hospital forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.0%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4WK's forecast earnings growth (17% per year) is above the savings rate (-0.05%).

Earnings vs Market: 4WK's earnings (17% per year) are forecast to grow faster than the German market (7.8% per year).

High Growth Earnings: 4WK's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4WK's revenue (12.6% per year) is forecast to grow faster than the German market (4.9% per year).

High Growth Revenue: 4WK's revenue (12.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4WK's Return on Equity is forecast to be low in 3 years time (7.7%).


Past Performance

How has Wenzhou Kangning Hospital performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


1.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4WK has high quality earnings.

Growing Profit Margin: 4WK's current net profit margins (6.4%) are higher than last year (4.4%).


Past Earnings Growth Analysis

Earnings Trend: 4WK's earnings have grown by 1.6% per year over the past 5 years.

Accelerating Growth: 4WK's earnings growth over the past year (83.7%) exceeds its 5-year average (1.6% per year).

Earnings vs Industry: 4WK earnings growth over the past year (83.7%) exceeded the Healthcare industry 55.1%.


Return on Equity

High ROE: 4WK's Return on Equity (5.2%) is considered low.


Financial Health

How is Wenzhou Kangning Hospital's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4WK's short term assets (CN¥783.8M) exceed its short term liabilities (CN¥554.2M).

Long Term Liabilities: 4WK's short term assets (CN¥783.8M) exceed its long term liabilities (CN¥484.6M).


Debt to Equity History and Analysis

Debt Level: 4WK's net debt to equity ratio (18.5%) is considered satisfactory.

Reducing Debt: 4WK's debt to equity ratio has increased from 7.3% to 41.1% over the past 5 years.

Debt Coverage: 4WK's debt is well covered by operating cash flow (38.8%).

Interest Coverage: 4WK's interest payments on its debt are well covered by EBIT (6.7x coverage).


Balance Sheet


Dividend

What is Wenzhou Kangning Hospital current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.77%

Forecast Dividend Yield

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 4WK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 4WK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 4WK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 4WK's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: 4WK is not paying a notable dividend for the German market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 4WK has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.7yrs

Average management tenure


CEO

Lianyue Wang (52 yo)

10.67yrs

Tenure

CN¥483,277

Compensation

Ms. Lianyue Wang serves as General Manager at Wenzhou Kangning Hospital Co., Ltd. Since September 2011, and has been its Executive Director since September 22, 2014 were she is primarily responsible for th...


CEO Compensation Analysis

Compensation vs Market: Lianyue's total compensation ($USD71.73K) is below average for companies of similar size in the German market ($USD390.84K).

Compensation vs Earnings: Lianyue's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: 4WK's management team is seasoned and experienced (7.7 years average tenure).


Board Members

Experienced Board: 4WK's board of directors are considered experienced (4.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Wenzhou Kangning Hospital Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Wenzhou Kangning Hospital Co., Ltd.
  • Ticker: 4WK
  • Exchange: DB
  • Founded: 1996
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: HK$872.898m
  • Listing Market Cap: HK$105.574m
  • Shares outstanding: 72.14m
  • Website: https://www.knhosp.cn

Number of Employees


Location

  • Wenzhou Kangning Hospital Co., Ltd.
  • No.1 Shengjin Road
  • Huanglong Residential District
  • Wenzhou
  • Zhejiang Province
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/17 00:00
End of Day Share Price2022/05/17 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.